Clinical trials
Psychotherapy clinical trials
Below are recruiting psychotherapy clinical trials, each written for real people, not researchers. We’re tracking 143 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07040462Recruiting
Parent-child therapy after the 2023 Turkish earthquake
This study tests a therapy for young children (ages 3–6) and their parents who lived through the 2023 Kahramanmaraş earthquake. It aims to help kids heal from trauma by improving the parent-child bond through weekly sessions.
Istanbul, IstanbulAges 3–65 - NCT06991166Recruiting
A therapy study for new mothers with depression whose baby is in the NICU
This study tests a new talk therapy program to help new mothers with depression whose babies are in the neonatal intensive care unit (NICU). You may join if you gave birth in the last year and have signs of depression, like a diagnosis or certain feelings.
Hackensack, New JerseyAges 18 years+ - NCT06954025Enrolling by invitationPhase 2
MDMA therapy for PTSD inpatients
This trial tests whether high-dose MDMA, given during intensive inpatient therapy, can help people with PTSD that hasn't improved with other treatments. It takes place at a specialized trauma center and involves several therapy sessions with the drug.
OegstgeestAges 18 years+ - NCT06818994RecruitingPhase 1
Psilocybin therapy for low mood in advanced cancer
This trial tests if a medicine called psilocybin, given with talk therapy, can safely help people with advanced cancer who feel very demoralized. Demoralization is a deep sense of hopelessness or loss of meaning. The goal is to see if this treatment can improve your emotional well-being.
Kingston, OntarioAges 18–70 - NCT06559826RecruitingPhase 2
Ketamine therapy with or without talk for depression
This study compares ketamine alone to ketamine combined with psychotherapy for treating depression. It may help if you have moderate to severe depression and want to see if adding talk therapy improves results.
New York, New YorkAges 18–90 - NCT06597864Recruiting
A pilot study of 7-step therapy for self-disorder in early psychosis
This trial tests a new type of talk therapy that helps people with early psychosis explore unusual experiences with their sense of self. It might be a good fit if you've been diagnosed with a psychotic disorder within the last 3 years or have psychosis risk syndrome, and you're motivated to work on these experiences.
Sandvika, BærumAges 18–39 - NCT06538675Enrolling by invitation
Comparing different talk therapies for adults
This study compares different types of talk therapy to see which works best. It is for adults who need psychotherapy and can complete questionnaires in German.
Salzburg, State of SalzburgAges 18–80 - NCT06200155RecruitingPhase 2
Psilocybin therapy for advanced cancer patients with anxiety or depression
This trial tests whether a drug called psilocybin, given with therapy, can help people with advanced cancer who are feeling anxious or depressed. You must have a stable cancer and be willing to travel to Houston for treatment.
Houston, TexasAges 25 years+ - NCT06105502Recruiting
Studying how therapy training helps students and patients
This trial looks at how training and supervision for new therapists affects their skills and patient outcomes. It may help improve how therapists are trained in public healthcare.
Stockholm, Stockholm CountyAges Any age - NCT06044675RecruitingPhase 2
MDMA plus therapy for PTSD – a study with a partner
This study tests whether MDMA, combined with a type of talk therapy called CBCT (cognitive behavioral conjoint therapy), is more effective than CBCT alone for treating PTSD. You and a close partner will both participate in therapy sessions and take MDMA together.
Toronto, OntarioAges 18–80 - NCT04882839RecruitingPhase 2
Therapy with psilocybin for severe OCD symptoms
This Phase 2 study tests whether psilocybin-assisted psychotherapy can reduce symptoms in adults with severe, treatment-resistant OCD. It also focuses on safety and whether this approach is practical to run.
BeershebaAges 18–65 - NCT05929911Recruiting
Talk therapy for PTSD in people living with HIV
This trial tests whether trauma-focused psychodynamic talk therapy can reduce symptoms of post-traumatic stress disorder (PTSD) in people who also live with HIV. It may help by offering structured therapy alongside stable medication.
The Bronx, New YorkAges 18–65 - NCT05925322Recruiting
Social reward therapy for depression-related suicidal thoughts
This study looks at whether “social reward” psychotherapy can change brain activity and reduce suicidal thoughts in adults ages 50–80 who also have major depression. You may be offered psychotherapy along with brain scans to see how your brain responds over time.
New York, New YorkAges 50–80 - NCT05585229RecruitingPhase 2
Psilocybin therapy to help you taper opioid pain medicine
This Phase 2 study tests a structured, therapist-led treatment using standardized natural psilocybin to help people reduce or stop long-term opioid use for chronic (non-cancer) pain. It’s mainly for those who have tried tapering before but couldn’t, and who are motivated to try again.
Kelowna, British ColumbiaAges 19–75 - NCT04763720Enrolling by invitation
Therapy for kids with attachment and trauma difficulties
This trial studies a special type of parent-and-child therapy called Dyadic Developmental Psychotherapy (DDP) for children who struggle with relationships or attachment after trauma, including neglect or emotional abuse. It may help families improve safety, closeness, and communication through guided sessions.
Skien, Vestfold Og TelemarkAges 5–99 - NCT04519229Enrolling by invitation
Feasibility study of child-parent therapy for foster infants and toddlers
This study tests whether a therapy program called Child-Parent Psychotherapy is practical and helpful for very young children in foster care and the adults caring for them. It’s mainly a “feasibility” study, meaning it focuses on whether the program can be delivered and followed in real life.
VaxjoAges birth–6 years - NCT04106713Recruiting
Understanding change across different psychotherapies for anxiety and depression
This study looks at how people change during different types of psychotherapy for anxiety and depression. It aims to understand which treatments work best for different people.
Singapore, SingaporeAges 18–99 - NCT07764536Recruiting
Parent training plus a digital tool for child temper outbursts
This trial tests whether a digital tool can make parent training more effective for children who have frequent temper outbursts and irritability. The training helps parents learn skills to manage their child's behavior, and the digital tool may help them practice and apply those skills.
Bethesda, MarylandAges 8–13 - NCT07868913RecruitingPhase 2
Ketamine and therapy for suicidal thoughts in the ER
This study tests whether a single dose of ketamine, given by injection in the emergency department, combined with brief psychotherapy, can quickly reduce suicidal thoughts and keep you safe. It aims to find fast-acting relief for people in crisis, possibly helping you feel better sooner and reducing the risk of future attempts.
Fort Hood, TexasAges 18–70 - NCT03846375Recruiting
Therapy trial for self-harm and suicidal thoughts
This study looks at emotional regulation during and alongside standard outpatient dialectical behavior therapy (DBT) for people who have self-harmed or had suicidal thoughts. It may help the team understand which emotions or patterns change with treatment.
BergenAges 18–65 - NCT04911829Recruiting
Program for persistent low-grade depression and treatment changes
This trial looks at how treatment for persistent depressive disorder (long-lasting low mood) affects real-world costs and the process of changing treatments. It may help people who have tried some treatments before and need a practical plan moving forward.
Vikersund, BuskerudAges 18–70 - NCT04892251RecruitingPhase 1/Phase 2
Ketamine-assisted therapy for opioid use disorder
This trial tests whether ketamine-assisted therapy can help people with opioid use disorder, alongside standard treatment with buprenorphine. It also looks at whether you can safely take part in group mindfulness-style sessions during the study.
Salt Lake City, UtahAges 18 years+ - NCT06279598Recruiting
Predicting PTSD treatment success and handling non-response (PT-STRESS)
This study looks at how well PTSD treatments work and what happens when they don't. It tests ways to predict if a treatment will be successful for you.
DeventerAges 18–65 - NCT05995769RecruitingPhase 2
Psilocybin therapy with talk therapy for alcohol problems
This trial tests whether psilocybin (the active ingredient in magic mushrooms), given with talk therapy, can help people who want to reduce their heavy drinking. It is for people with at least moderate alcohol use disorder who are motivated to change.
Calgary, AlbertaAges 22–65
Hear when a new Psychotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for psychotherapy?
- Yes. Clin2 currently lists 143 recruiting psychotherapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a psychotherapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a psychotherapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.